Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diagnostic for Sepsis

a sepsis and sepsis technology, applied in the field of diagnosis, can solve the problems of poorly characterized relations, achieve the effect of decreasing reducing the risk of organ failure, and reducing the risk of a subj

Inactive Publication Date: 2017-03-16
HANCOCK ROBERT E W
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is about using antibiotics to treat sepsis or prevent it from happening. It is a method that can reduce the risk of organ failure in a person.

Problems solved by technology

However, this relationship remains poorly characterized, in part due to the limitations of the ex vivo cytokine assays employed to date.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diagnostic for Sepsis
  • Diagnostic for Sepsis
  • Diagnostic for Sepsis

Examples

Experimental program
Comparison scheme
Effect test

example 1

Definition and Characterization of the Signature

[0231]Confirmed Sepsis Patients Express an “Endotoxin Tolerance Signature.”

[0232]To characterize the development of the immunosuppressive stage in sepsis and to conclusively determine its links with endotoxin tolerance, a robust bioinformatics approach was taken. To define an endotoxin tolerance gene signature, microarray analyses of human peripheral blood mononuclear cells (PBMC) treated either once with LPS to model inflammatory signalling, or twice to model endotoxin tolerance was used. An “Endotoxin Tolerance Signature” (Table A below), comprising 99 genes was identified based on genes uniquely differentially expressed in endotoxin-tolerant PBMCs, but not inflammatory PBMCs, as compared to controls. For comparison, we defined an “Inflammatory Signature” from previous PBMC microarray data (Pena et al., 2011) and an in vivo experimental endotoxemia dataset (Calvano et al., 2005) (FIG. 1, Table 4). Having defined a genetic signature f...

example 2

New Therapies Based on the Endotoxin Tolerance Signature

[0252]Network analysis of the Endotoxin Tolerance genes revealed that most of the genes formed a very tight subnetwork strongly suggesting that the signature reflects critical mechanisms likely related to immune dysfunction in sepsis patients (FIG. 8).

[0253]One implication of knowing that a patient is going to soon suffer from sepsis is that one can apply an appropriate antibiotic therapy comprising a cocktail of the most potent drugs. Current clinical guidelines indicate that while waiting for culture results, a patient should be started on intravenous ceftriaxone and azithromycin. The purpose of this regimen is to try to avoid major resistance issues since only a portion of the patients who are thought to have the potential to acquire sepsis actually do so (see e.g. Table 3). Knowing that a patient has sepsis very early in the course of disease would enable physicians to prescribe the most aggressive therapies to try to reduc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
timeaaaaaaaaaa
nucleic acidaaaaaaaaaa
Login to View More

Abstract

A method of diagnosing severe sepsis prior to definitive clinical diagnosis. A pattern of gene expression that correlates strongly with a future diagnosis of severe sepsis and organ failure was identified in patients who had their blood drawn at first clinical presentation. The methods comprise identifying a pattern of two or more polynucleotides, whereby the altered expression of these polynucleotides correlates with prospective and actual sepsis. Also methods of identifying agents for treating sepsis based on the characteristics of this gene expression pattern are provided.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application claims priority to U.S. provisional patent application No. 61 / 953,458 filed on Mar. 14, 2014. The entire contents of U.S. provisional patent application No. 61 / 953,458 are incorporated by reference herein.FIELD OF THE INVENTION[0002]The present invention relates to the field of diagnostics and, in particular, to a unique set of DNA sequences that in combination enable the early diagnosis of sepsis, and the prediction of severe sepsis and / or organ failure.BACKGROUND OF THE INVENTION[0003]Sepsis continues to be the major infection-related cause of death globally, leading to an estimated 8.5% of deaths (5 million) annually [Angus D, et al. Critical Care Medicine 2001; 29(7): 1303-10; Kumar G, Kumar N, Taneja A, et al. Chest 2011; 140:1223-31]. Despite advances in modern medicine including new antibiotics and vaccines, early recognition and best practice treatments, and efficient well-equipped intensive care units [Angus D et ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68A61K35/15C12N15/10
CPCC12Q1/689C12N15/1068C12Q2600/172C12Q2600/158C12Q2600/136A61K35/15C12Q1/6883C12Q2600/118C12Q2600/16A61P31/04
Inventor HANCOCK, ROBERT E. W.PENA SERRATO, OLGA M.HANCOCK, DAVID G.BOYD, JOHN
Owner HANCOCK ROBERT E W
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com